PATENT CLAIM ANALYSIS

Application Number: 15942345
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["540", "360000"]

Abstract:
A compound is represented as Formula I, a tautomer thereof, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof: Compounds of Formula I are inhibitors of N-acylethanolamine hydrolyzing acid amidase (NAAA).

Claim (Index 3):
The compound of  claim 1 , wherein:\n Z is NCS, CN, CH 2 CN, CH(CH 3 )CN, or C(cyclopropane)CN; W is (CH 2 ) n  where n is 0 or 1; D is CH 2 , CH 2 CH 2 , or pyridyl, with the proviso that where D is pyridyl, M is C or CR, and Z is \u2014CN and M is attached to a N atom of the pyridyl group; Y is (CH 2 ) n , O(CH 2 ) n , NR 3 (CH 2 ) n , (CH 2 ) n O, (CH 2 ) n NH, or (CH 2 ) n NCH 3 ; V is O, NCH 3 , SO 2 , CONCH 3 , or (CH 2 ) n  wherein n is 0 or 1; B is (CH 2 ) n\u2032 , phenyl, or a 5 or 6-member heterocyclyl; and A is phenyl or a 5 or 6-member heterocyclyl;

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.31034
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15311817', '15253773', '14770331', '15763724', '14169770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7368608983999331
- 35 USC 102 Novelty (BERT): 0.6097660815541905
- Combined Prediction Score: 0.7241514167153589
- Mean Citation Score: 384.380926
- Max Citation Score: 623.34186
- Similarity Product: 450.024104607178

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test